ConductScience.org, home

Trial · NCT07909369

Medial Unloader Brace After Root Repair

NCT07909369, Not applicable, Recruiting, NYU Langone Health

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Medial Unloader Brace After Root Repair. Trials, record NCT07909369. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909369

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Medial Unloader Brace After Root Repair
NCT number
NCT07909369
Status
Recruiting
Phases
Not applicable
Enrollment
48 participants, estimated
Lead sponsor
NYU Langone Health
Conditions
Arthroscopic Medial Meniscus Posterior Root Repair
Interventions
Medial unloader valgus knee brace
First posted
2026-11-02
Last updated
2026-11-02

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in medial meniscal extrusion on coronal T2-weighted MRI at 5 months as defined by greater than 3 mm of extrusion from the tibial plateau.Baseline, Month 5
SecondaryChange in Knee Injury and Osteoarthritis Outcome Score (KOOS)Baseline, Month 5
The KOOS survey is comprised of 42 questions. The questions are divided into 5 sub-categories: symptoms (7 questions), pain (9 questions), function/daily living (17 questions), function/sports and recreational activities (5 questions), and quality of life (4 questions). The total range for each sub-category is 0-100, making the total range for the whole survey 0-500. The higher the score, the worse the symptoms and pain/ higher difficulty in function.
SecondaryChange in Lysholm knee scoring scaleBaseline, Month 5
The Lysholm knee scoring scale is a 100-point patient-reported questionnaire designed to assess functional knee ligament injuries. It evaluates eight areas-limp, support, locking, instability, pain, swelling, stair climbing, and squatting-with higher scores (up to 100) indicating better function.
SecondaryChange in Tegner Activity Scale (TAS)Baseline, Month 5
The TAS is a self-administered patient-reported measure that describes the level of work- and sports-based activity in which a patient can engage. The TAS is a one-item questionnaire that is scored on an 11-item scale (0 to 10) based on the patient's reported level of activity/work. A level of 0 represents maximum disability while a level of 10 represents elite sports athletes.
SecondaryChange in Visual Analogue Scale (VAS) for Pain scoreBaseline, Month 5
VAS is a tool widely used to measure pain. A patient is asked to indicate his/her perceived pain intensity (most commonly) along a 10 mm horizontal line, and this rating is then measured from the left edge (=VAS score). The total score range is 0 (no pain) to 10 (worst pain imaginable); the higher the score, the worse the pain.
SecondaryChange in medial femoral condyle cartilage thicknessBaseline, Month 5
SecondaryChange in tibial plateau cartilage thicknessBaseline, Month 5
SecondaryNumber of participants who could not tolerate the braceEnd of study (Up to 5 months)
SecondaryRate of reoperationEnd of study (Up to 5 months)

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07909369

GET https://conductscience.org/api/trials/v1/NCT07909369/registered